Optimizing Glioblastoma Temozolomide Chemotherapy Employing Lentiviral-based Anti-MGMT shRNA Technology

Despite treatments combining surgery, radiation-, and chemotherapy, patients affected by glioblastoma (GBM) have a limited prognosis. Addition of temozolomide (TMZ) to radiation therapy is the standard therapy in clinical application, but effectiveness of TMZ is limited by the tumor's overexpre...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Viel, Thomas, Monfared, Parisa, Schelhaas, Sonja, Fricke, Inga B, Kuhlmann, Michael T, Fraefel, Cornel, Jacobs, Andreas H
Natura: Artigo
Lingua:Inglês
Pubblicazione: Nature Publishing Group 2013
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3589165/
https://ncbi.nlm.nih.gov/pubmed/23319055
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mt.2012.278
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi